Concomitant Gemcitabine (Gemzar®) and Extended Nodes Irradiation in the Treatment of Pancreatic and Biliary Carcinoma: A Phase I Study

Publisher： Karger

E-ISSN： 2296-5262|26|4|325-329

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.26, Iss.4, 2003-09, pp. : 325-329

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chemoradiotherapy in Patients with Pancreatic Carcinoma: Phase-I Study with a Fixed Radiation Dose and Escalating Doses of Weekly Gemcitabine

By  

Pancreatology, Vol. 6, Iss. 1-2, 2006-04 ,pp. : 109-116

Karger

Access to resources Recommend Favorite

Phase II Study of Cisplatin Combined with Weekly Gemcitabine in the Treatment of Patients with Metastatic Pancreatic Carcinoma

By  

Pancreatology, Vol. 6, Iss. 6, 2007-03 ,pp. : 635-641

Karger

Access to resources Recommend Favorite

Phase I study of gemcitabine, cisplatin, and S‐1 combination therapy for patients with untreated advanced biliary tract cancer

By  

JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, Vol. 22, Iss. 9, 2015-09 ,pp. : 669-674

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase II Study of Gemcitabine in Combination with Docetaxel in Patients with Advanced Pancreatic Carcinoma (E1298)

By  

Oncology, Vol. 66, Iss. 4, 2004-06 ,pp. : 303-309

Karger

Access to resources Recommend Favorite

Weekly Gemcitabine and 24-Hour Infusional 5-Fluorouracil in Advanced Pancreatic Cancer: A Phase I–II Study

By  

Oncology, Vol. 64, Iss. 2, 2003-02 ,pp. : 139-145

Karger

Access to resources Recommend Favorite